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ABSTRACT Cells of the monocyte/macrophage lineage play important roles in the
pathogenesis of inflammatory bowel diseases, but they are also present in the nor-
mal healthy intestine, where they are critical for maintaining homeostasis. It has been
unclear whether the proinflammatory roles of intestinal macrophages reflect altered be-
havior of the existing resident cells, or whether they involve recruitment of a distinct cell
type. Here, we have explored these ideas using the model of colitis induced by Helico-
bacter hepaticus in the context of neutralization or deletion of interleukin-10 (IL-10).
Granulocytes and monocytes made up most of the inflammatory myeloid infiltrates
found in the colon of H. hepaticus-infected colitic mice, rising to a peak within 2 weeks
of H. hepaticus inoculation but taking several months to resolve completely. The inflam-
matory response was dependent on the combined presence of H. hepaticus and ab-
sence of IL-10 and was accompanied by increased production of inflammatory media-
tors such as IL-1, tumor necrosis factor alpha (TNF-), IL-6, and IL-23p19 by infiltrating
myeloid cells, mostly relatively immature cells of the macrophage lineage that express
intermediate levels of CX3CR1. In contrast, the population of mature CX3CR1hi macro-
phages did not expand as markedly during colitis, and these cells made little contribu-
tion to inflammatory mediator production. Taking into account their numerical domi-
nance in the myeloid compartment, we conclude that newly recruited monocytes are
the main source of proinflammatory mediators in colitis induced in the absence of IL-10
signaling and that altered behavior of mature macrophages is not a major component
of this pathology.
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Inflammatory bowel diseases (IBD), comprising Crohn’s disease and ulcerative colitis,are growing health problems in the developed world. Although recent advances have
helped elucidate some of the mechanisms underlying IBD, treatment remains unsatis-
factory and individual regimes are seldom effective for all patients. Thus, a better
understanding of the processes and cells involved in the pathogenesis of IBD could
help develop new targets for therapy.
Macrophages (Ms) have received considerable attention in recent years because of
their potential roles in both steady-state and inflamed intestines (1–3). Resident Ms
are abundant in the healthy intestine, where they are involved in clearance of apoptotic
cells and play a crucial role in maintaining homeostasis, ingesting and killing commen-
sal bacteria that cross the epithelial barrier (reviewed in reference 2). In contrast to
other tissues, these processes do not provoke overt inflammation in the intestine, due
to powerful control mechanisms that prevent local Ms from producing proinflamma-
tory mediators in response to stimuli such as Toll-like receptor (TLR) ligands (4, 5).
However, findings from both IBD and experimental models of the disease have dem-
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onstrated that Ms are also crucial components of the inflammatory infiltrate (4, 6–9),
raising the possibility of exploiting them as therapeutic targets.
We and others have shown recently that intestinal Ms originate from Ly6Chi blood
monocytes that continuously enter the colonic mucosa and differentiate locally
through a series of intermediaries. Although present in only small numbers, cells with
the phenotypic and morphological features of Ly6Chi monocytes can be found in the
steady-state mucosa. However, major transcriptional differences exist between these
and Ly6Chi monocytes found in blood, suggesting that the differentiation process
occurs immediately after monocytes enter the colonic mucosa (6, 10). Importantly, as
monocytes mature, they progressively acquire anti-inflammatory properties, such as
constitutive production of interleukin-10 (IL-10) and hyporesponsiveness to, e.g., TLR
ligands (6, 11, 12). However, this physiological process is disrupted during inflammation
(6, 12, 13), and understanding how this change in M behavior occurs would be an
important advance in our knowledge of how to prevent and treat IBD. Studies of the
colitis induced by feeding dextran sodium sulfate (DSS) suggest that the tissue pathol-
ogy is paralleled by the accumulation of highly proinflammatory monocytes, whereas
the fully differentiated Ms that remain do not alter their behavior and retain their
anti-inflammatory characteristics (6, 12). However, it is not clear if this pattern extends
to other forms of intestinal inflammation, particularly under conditions where there are
intrinsic defects in the mechanisms that normally control resident M function.
The IL-10–IL-10 receptor (IL-10R) axis is an important brake on M activation,
particularly in the intestine, where deletion of either the cytokine or its receptor leads
to spontaneous onset of inflammation in association with hyperresponsiveness of Ms
(13–19). Furthermore, humans with nonfunctional mutations in IL-10, IL10RA, or IL10RB
develop severe enterocolitis within the first months of life (reviewed in reference 20).
Here, we have examined the relationship between IL-10 and the differentiation of
intestinal Ms in inflammation in more depth by exploring M behavior during colitis
induced by inoculation of mice with Helicobacter hepaticus in the absence of IL-10
signaling (21, 22). We report that H. hepaticus-induced colitis is characterized by the
accumulation of proinflammatory CD11b myeloid cells that are hyperresponsive to
TLR stimulation. Most of these cells are monocytes and their immediate progeny that
express intermediate levels of CX3CR1 and that have not differentiated fully into
anti-inflammatory, resident-type CX3CR1hi Ms. We further show that the expansion of
cells in the monocyte/M compartment is maintained for several months before
returning to normal levels as the inflammation resolves.
RESULTS
Expansion of myeloid cells in the large intestine of H. hepaticus-infected colitic
Il10/ mice. To begin to characterize the innate immune response in the large
intestine following H. hepaticus inoculation, wild-type (WT) and Il10/ mice were
inoculated intragastrically (i.g.) with the bacterium, and the cellular composition of
lamina propria (LP) cells from pooled ceca and colons was examined 2 weeks later, the
time point at which pathology peaks in Il10/ hosts (23). As expected, H. hepaticus-
infected Il10/ mice displayed enhanced cellularity of the large intestinal LP compared
with uninfected controls (Fig. 1A, left panel), with greatly expanded proportions and
numbers of CD45 hematopoietic cells (Fig. 1A, middle and right panels), consisting of
B cells, CD4 T cells, and CD11b myeloid cells (Fig. 1B). Only minor increases were
observed in the proportion and number of LP CD45 cells in H. hepaticus-infected WT
mice (Fig. 1A), and the size of the CD11b myeloid compartment was unaffected in
these hosts (Fig. 1B, right panel). More detailed analysis of the early cellular kinetics
following H. hepaticus inoculation of Il10/ animals revealed that the numbers of total
CD45 cells and of CD11b myeloid cells were significantly increased in H. hepaticus-
infected Il10/ mice on day 5 postinfection (p.i.) and expanded steadily until day 11
p.i. (Fig. 1C). Thus, H. hepaticus-driven typhlocolitis in Il10/ mice is associated with
massive infiltration by both lymphoid and myeloid cells.
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Myeloid cells from H. hepaticus-infected Il10/ mice display a proinflamma-
tory phenotype. To understand how the expansion of the myeloid compartment
might contribute to the colitis in Il10/ hosts, we examined the cytokine secretion
profile of CD11b cells from uninfected and H. hepaticus-infected Il10/ mice. To this
end, large intestinal LP cells were stimulated with the TLR ligand Pam3CSK4, and tumor
necrosis factor alpha (TNF-) production was examined by intracellular cytokine stain-
ing (ICS). TLR ligation of LP cells from H. hepaticus-infected Il10/ animals resulted in
an 3-fold increase in the proportion of CD11b cells producing TNF- compared with
cells cultured in medium alone (Fig. 2A, bottom panels), and this translated to a highly
significant increase in the absolute number of TNF- CD11b cells in the LP of





















































































































































































































FIG 1 Expansion of myeloid cells in the large intestine of H. hepaticus-infected colitic Il10/ mice. WT and
Il10/ mice were inoculated with H. hepaticus, and LP cells were isolated from pooled cecum and colon 2
weeks (A and B) or 1, 3, 5, 8, and 11 days (C) later and examined by flow cytometry. Uninfected mice were
included as controls. (A) Total numbers of LP cells (left panel) and percentages (middle panel) and total
numbers (right panel) of CD45 hematopoietic cells from uninfected (white bars) and 2-week H. hepaticus-
infected (black bars) WT and Il10/ mice. (B) Numbers of B220 CD19 B cells (left panel), CD3 CD4 T cells
(middle panel), and CD11b myeloid cells (right panel) from uninfected (white bars) and 2-week H. hepaticus-
infected (black bars) WT and Il10/ mice. Data in panels A and B are from one representative experiment out
of at least three performed, and bars represent means  standard deviations from 3 mice per group. (C) Total
numbers of LP cells (left panel), CD45 hematopoietic cells (middle panel), and CD11b cells (right panel)
from pooled cecum and colon of 1-, 3-, 5-, 8-, and 11-day H. hepaticus-infected Il10/ mice. Data are pooled
from two individual experiments and are the means  standard deviations from 5 to 6 LP cell preparations
(each pooled from 1 to 2 animals) from H. hepaticus-infected mice and 8 cell preparations (each pooled from
2 to 3 animals) from uninfected mice. Significance was determined by one-way ANOVA followed by Tukey’s
multiple-comparison test. *, P  0.05; ***, P  0.001; ****, P  0.0001, when comparing H. hepaticus-infected
and uninfected mice (A and B) or comparing each time point to uninfected mice (C).
Myeloid Cells in H. hepaticus Colitis Infection and Immunity














































proportion of TNF- CD11b cells from uninfected Il10/ animals was unaffected by
Pam3CSK4 stimulation and remained at levels similar to those seen in naive WT colon
(Fig. 2A, upper panels, and B).
To extend these analyses, we next purified CD11b cells from the large intestinal LP
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FIG 2 Large intestinal CD11b myeloid cells from H. hepaticus-infected Il10/ mice secrete elevated amounts
of proinflammatory cytokines following TLR stimulation. Il10/ mice were inoculated with H. hepaticus, and LP
cells were isolated from pooled cecum and colon 2 weeks later. Uninfected mice were included as controls. (A
and B) Large intestinal LP cells were cultured in medium alone or stimulated with 10 g/ml Pam3CSK4 for 4 h
with 10 g/ml brefeldin A during the last 3 h and then stained for CD45, CD11b, and TNF- or appropriate
isotype control. Dot plots in panel A are gated on CD45 CD11b LP cells from uninfected (Uninf.; upper panels)
and 2-week H. hepaticus-infected Il10/ mice (Hh-inf.; lower panels), and numbers ( standard deviations) of
TNF- CD11b cells per mouse in panel B were calculated from the percentages in panel A and the total
number of cells isolated from each mouse. Data in panels A and B are representative of two independent
experiments performed with 3 individual mice per group. Significance was determined by one-way ANOVA
followed by Tukey’s multiple-comparison test. **, P  0.01; ****, P  0.0001. (C) Large intestinal LP CD11b
myeloid cells were FACS purified from uninfected (white bars) and 2-week H. hepaticus-infected (black bars)
Il10/ mice and stimulated in vitrowith LPS (10 g/ml), Pam3CSK4 (10 g/ml), or SHelAg (10 g/ml) or cultured
in medium alone. After 24 h, supernatants were collected and analyzed for the presence of IL-12p40, IL-6, and
TNF-. Bars represent means  standard deviations for quadruplicate (IL-12p40 and IL-6) or duplicate (TNF-)
ELISA values (where each value represents a separate culture) combined from two independent experiments.
(D) RT-qPCR analysis of IL-12p35 (Il12a), IL-12p40 (Il12b), and IL-23p19 (Il23a) transcripts relative to HPRT in sorted
CD11b cells from uninfected (white bars) or 2-week H. hepaticus-infected (black bars) Il10/ mice. Bars
represent means  standard deviations from three (for uninfected mice) and four (for H. hepaticus-infected
mice) individual experiments, each consisting of cells pooled from 5 to 6 mice. Significance was determined by
the Mann-Whitney U test. *, P  0.05.
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activated cell sorting (FACS) and cultured them overnight with lipopolysaccharide (LPS),
Pam3CSK4, or soluble H. hepaticus antigen (SHelAg), before assessing the levels of a
wider range of cytokines using enzyme-linked immunosorbent assay (ELISA) and
FlowCytoMix. CD11b cells from H. hepaticus-infected Il10/ mice secreted larger
amounts of IL-12p40, IL-6, and TNF- after all forms of stimulation than did CD11b
cells from uninfected Il10/ hosts (Fig. 2C). When analyzed directly ex vivo, FACS-
purified CD11b cells from H. hepaticus-infected Il10/ mice also contained higher
levels of Il12a and Il23a transcripts than did CD11b cells from uninfected controls,
whereas the levels of Il12b accumulation were similar in the two populations (Fig. 2D).
Thus, the expanded myeloid cell compartment in the large intestine of H. hepaticus-
infected colitic Il10/ mice displays proinflammatory characteristics.
Composition of the myeloid compartment in H. hepaticus-infected Il10/ mice.
We next set out to explore what cell types accounted for the change within the
CD11b compartment during H. hepaticus colitis. To do this, we exploited multiparam-
eter flow cytometry and rigorous gating strategies that we have developed recently to
characterize the myeloid compartment of the intestinal LP, allowing precise identifica-
tion of monocytes, Ms, eosinophils, neutrophils, and dendritic cells (DCs) (6) (see Fig.
S1 in the supplemental material). We also omitted the Percoll gradient step during the
purification to exclude the possibility of selective loss of individual cell types. These
approaches confirmed marked changes in the composition of the myeloid cell com-
partment in the colon 2 weeks after H. hepaticus inoculation of Il10/ mice, compared
with uninfected Il10/ mice or H. hepaticus-infected WT mice (Fig. 3A). Ly6G neu-
trophils and SSChi (major histocompatibility complex class II-negative [MHCII]) eosin-
ophils (Fig. 3A, B, and C) accounted for a substantial part of the infiltration found in H.
hepaticus-infected Il10/ mice, and no significant differences were seen in these
granulocyte populations in H. hepaticus-infected WT mice or in uninfected Il10/ mice
compared with uninfected WT mice (Fig. 3A, B, and C).
H. hepaticus-infected Il10/ mice also showed marked expansion in the numbers of
nongranulocytic myeloid cells (Fig. 3A, D, and E), and we therefore explored the
contribution of monocytes and Ms in more detail. To do this, we focused on cells
expressing the pan-M markers F4/80 and/or CD64 (Fig. S1) and examined the mono-
cyte/M differentiation continuum that we and others have defined in the colonic LP
(6, 24, 25). This so-called “monocyte waterfall” consists of newly arrived Ly6Chi MHCII
monocytes, differentiating Ly6C MHCII monocytes, and more mature Ly6C MHCII
cells that include tissue-resident Ms (Fig. 3D). H. hepaticus-infected Il10/ mice
showed marked increases in the proportions and absolute numbers of Ly6Chi MHCII
and Ly6C MHCII cells, which were increased by 125-fold and 155-fold, respectively,
compared with their numbers in uninfected Il10/ mice (Fig. 3D and E). There was also
a modest but significant increase in the number of more mature Ly6C MHCII cells in
H. hepaticus-infected Il10/ mice (Fig. 3E, right panel). H. hepaticus-infected WT mice,
which do not develop colitis, showed some evidence of increased infiltration by Ly6Chi
MHCII, Ly6C MHCII, and Ly6C cells, while uninfected Il10/ mice had slightly
higher numbers of Ly6C MHCII cells than their naive WT counterparts; however,
these differences were modest and did not attain statistical significance (Fig. 3E).
DCs were identified as CD11c MHCII CD64 cells among LP leukocytes (26),
and their numbers increased in H. hepaticus-infected mice compared with control
Il10/ mice (Fig. S2A). The frequency of DCs among LP cells of H. hepaticus-
infected Il10/ mice decreased compared to uninfected controls (data not shown),
most likely reflecting the increase in other leukocytes. Finally, there were minor
changes in the proportion of DC subsets identified on the basis of CD11b and
CD103 expression, although none of these changes reached statistical significance
(Fig. S2B).
Altered monocyte/M differentiation in H. hepaticus-infected colitic mice. The
accumulation of monocytes that we found in H. hepaticus colitis is reminiscent of our
own and other results from DSS- and T-cell-mediated colitis, where there appeared
to be an arrest in the local differentiation continuum that normally generates anti-
Myeloid Cells in H. hepaticus Colitis Infection and Immunity














































inflammatory, resident Ms (6, 12, 24). To examine whether a similar block was present
during H. hepaticus-induced colitis, we used Cx3cr1/gfp reporter mice, in which one
allele of the Cx3cr1 gene has been replaced with the gene encoding green fluorescent
protein (GFP) (27). This allows fully differentiated resident CX3CR1hi Ms to be distin-
guished from cells in the earlier CX3CR1int stages in the developmental continuum,
some of which would have been included among the Ly6C MHCII population that
we defined earlier. In this way, we could examine the relative roles of resident and
recently recruited Ms in H. hepaticus-induced inflammation, as well as explore how
these cells behave during the resolution of pathology that occurs at later stages after
bacterial inoculation (23). Because the Cx3cr1/gfp reporter mice are IL-10 sufficient, we
had to induce colitis by H. hepaticus inoculation plus weekly administration of anti-IL-
10R monoclonal antibody (MAb) (22). Consistent with our studies in Il10/ mice, this
resulted in massive accumulation of total leukocytes and CD11b myeloid cells in the
colonic mucosa by day 14 p.i. (Fig. 4A and B). However, by day 41 p.i., both compart-
ments had contracted significantly, and by day 77 p.i., they were both reduced almost
to baseline levels (Fig. 4A and B).
As in colitic Il10/ mice, the composition of the myeloid compartment was
markedly altered in anti-IL-10R-treated H. hepaticus-infected Cx3cr1/gfp mice, with a
large expansion of granulocytes and monocyte-derived cells at day 14 p.i., followed by










































































































































































































































FIG 3 Composition of the myeloid compartment in H. hepaticus-infected Il10/ mice. WT and Il10/ mice were inoculated with H. hepaticus, and colonic LP
cells were isolated 2 weeks later and examined by flow cytometry. Uninfected mice were included as controls. (A) Relative frequencies among total colonic
CD11b cells of Ly6G neutrophils, SSChi MHCII eosinophils, CD64 CD11c MHCII CD11b DCs, and Ly6C/MHCII-defined cells of the CD64 monocyte/
macrophage compartment (Ly6Chi MHCII, Ly6C MHCII, and Ly6C MHCII) from uninfected or H. hepaticus-infected WT and Il10/ mice. (B and C) Absolute
numbers of Ly6G neutrophils (B) and SSChi MHCII eosinophils (C) per colon of uninfected or H. hepaticus-infected WT and Il10/ mice. (D) Representative
expression of Ly6C and MHCII by CD11b Ly6G SSClo CD64 cells from uninfected or H. hepaticus-infected WT and Il10/ mice. The bar graph shows the
frequency among CD11b Ly6G SSClo CD64 cells of Ly6Chi MHCII, Ly6C MHCII, and Ly6C MHCII cells. (E) Absolute numbers of Ly6Chi MHCII, Ly6C
MHCII, and Ly6C MHCII cells per colon of uninfected or H. hepaticus-infected WT and Il10/ mice. Data are from one of two independent experiments
performed. Bars represent the means  standard deviations from 4 individual mice per group. Significance was determined by one-way ANOVA followed by
Tukey’s multiple-comparison test. ****, P  0.0001. Hh, H. hepaticus infected.
Bain et al. Infection and Immunity
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FIG 4 Monocyte differentiation is dysregulated in anti-IL-10R-treated H. hepaticus-infected colitic Cx3cr1/gfp mice. Cx3cr1/gfp mice were inoculated with H.
hepaticus and treated weekly with anti-IL-10R to induce colitis. The composition of the colonic myeloid compartment was then examined at 14, 41, and 77 days
postinfection and compared to uninfected mice or mice given H. hepaticus alone. (A and B) Absolute numbers of total CD45 (A) and CD11b (B) cells per colon
of H. hepaticus/anti-IL-10R-treated mice 14, 41, and 77 days after infection, compared with control mice (uninfected and H. hepaticus alone; data pooled from
day 14 to day 77 for these groups). (C) Relative frequencies among total colonic CD11b cells of Ly6G neutrophils, SSChi MHCII eosinophils, F4/80 CD11c
MHCII CD11b DCs, and Ly6C/MHCII-defined cells of the F4/80 monocyte/M compartment (Ly6Chi MHCII, Ly6C MHCII, and Ly6C MHCII) of mice as
in panel A. (D and E) Representative expression of Ly6C and MHCII by CD11b Ly6G SSClo F4/80 cells (D) and absolute numbers of Ly6Chi MHCII, Ly6C
MHCII, and Ly6C MHCII cells per colon (E) of mice as in panel A. (F) Representative expression of CX3CR1-GFP by Ly6C MHCII cells from uninfected mice,
mice inoculated with H. hepaticus alone, and mice receiving H. hepaticus plus anti-IL-10R when analyzed at 14, 41, and 77 days postinoculation. The histograms
for the uninfected mice and those infected with H. hepaticus alone are taken from the day 14 experiment. (G) Absolute numbers of CX3CR1int (left panel) and
CX3CR1hi (right panel) Ly6C MHCII cells per colon of mice as in panel A. Data are from one experiment, and bars represent the means  standard deviations
from 4 individual mice per group. Significance was determined by one-way ANOVA followed by Tukey’s multiple-comparison test. *, P  0.05; **, P  0.01; ***,
P  0.001.
Myeloid Cells in H. hepaticus Colitis Infection and Immunity














































myeloid infiltrate contained large numbers of Ly6Chi MHCII and Ly6C MHCII cells at
day 14 p.i. (Fig. 4C to E). The Ly6C MHCII population also expanded in number early
in colitis, but most of this expansion was accounted for by CX3CR1int cells (Fig. 4F), a
population that we have shown previously to be a further intermediary stage in the
local differentiation of monocytes (6). In parallel, there was a substantial decrease in the
proportion of fully mature CX3CR1hi Ms among the Ly6C MHCII cells at this time
(Fig. 4F), although their absolute numbers were increased and remained so throughout
the experiment (Fig. 4G). By day 41 p.i., the proportions and numbers of CX3CR1int cells
among Ly6C MHCII cells had contracted significantly, and by day 77 p.i., CX3CR1hi
cells had again come to dominate the Ly6C mature M compartment (Fig. 4F and G).
At this time, the numbers of Ly6Chi MHCII and Ly6C MHCII cells had also returned
to baseline levels (Fig. 4E).
The numbers of Ly6G neutrophils and CD11c CD11b F4/80 DCs were greatly
increased by day 14 p.i. in anti-IL-10R-treated H. hepaticus-infected Cx3cr1/gfp mice,
before falling at later times in parallel with the reduction in monocytes and Ms (Fig.
S3A and B). Interestingly, however, the numbers of colonic eosinophils remained high
in these mice until the end of the experiment on day 77 p.i. (Fig. S3C). All these H.
hepaticus-induced changes in myeloid cells were seen only when H. hepaticus-infected
Cx3cr1/gfp mice were also coadministered anti-IL-10R (Fig. 4 and data not shown).
Anti-IL-10R treatment alone of uninfected Cx3cr1/gfp mice did not result in leukocyte
accumulation in the colonic mucosa (Fig. S4), findings that are in agreement with those
that we previously reported for uninfected WT mice (22).
Together, our results demonstrate that the acute phase of H. hepaticus-induced
colitis is associated with accumulation of CX3CR1int monocytes and early-stage Ms,
consistent with the idea that there may be a block in the normal differentiation process.
Colonic CX3CR1int monocytes/Ms are the major producers of proinflamma-
tory cytokines during H. hepaticus colitis. Finally, we explored whether elicited
CX3CR1int cells were responsible for the production of proinflammatory mediators by
myeloid cells during colitis, or if this reflected altered behavior of the more mature
CX3CR1hi Ms. Quantitative reverse transcription-PCR (RT-qPCR) analysis showed
marked upregulation of mRNA transcripts for Il1b, Nos2 (inducible nitric oxide synthase
[iNOS]), Il23p19, and Il12p35 in CX3CR1int cells from anti-IL-10R-treated H. hepaticus-
infected mice at the peak of inflammation on day 14 compared with CX3CR1int cells
from control mice (Fig. 5A to D). In contrast, colonic CX3CR1hi Ms from anti-IL-10R-
treated H. hepaticus-infected mice showed only minor changes in mRNA levels of
proinflammatory mediators (Fig. 5). Thus, taking into account their numerical domi-
nance in the myeloid compartment, newly recruited CX3CR1int monocytes/Ms form
the predominant proinflammatory population in this model of colitis.
DISCUSSION
The results presented here underline the importance of the myeloid compartment
in the inflammatory colitis that occurs in mice infected with Helicobacter hepaticus
when IL-10-mediated signaling is absent. Using a variety of approaches to identify
myeloid lineages, including Cx3cr1/gfp mice, we show that an intense infiltrate of
CD11b cells appears early during infection and that this is made up of neutrophils,
eosinophils, Ly6Chi MHC–/ monocytes, and CX3CR1int Ms at the time of peak disease
at 2 weeks after H. hepaticus inoculation. While this confirms other work (28), we also
show here that this expansion of the monocyte/M compartment is sustained for up
to 11 weeks after infection, by which time other parameters of inflammation, such as
changes in myeloid cell subset composition, have returned to steady-state levels.
Importantly, the inflammatory changes required both infection with H. hepaticus and
neutralization of IL-10R signaling, with very few changes being seen in mice with H.
hepaticus infection alone or loss of IL-10 alone. Similarly, the greatly heightened
production of proinflammatory mediators in response to activation in vitro by intestinal
myeloid cells was fully dependent on these factors operating together. These results
confirm previous conclusions that H. hepaticus plays a crucial role in provoking intes-
Bain et al. Infection and Immunity














































tinal inflammation in the absence of IL-10-mediated immunoregulation and that pro-
inflammatory responses to this organism are normally restrained by IL-10 (21, 22, 29).
In previous work, we have shown that resident Ms in normal intestinal mucosa
are replenished continuously by Ly6Chi monocytes that differentiate via a number
of intermediary stages into mature, resident Ms (6, 11, 24). At early times after
inoculation with H. hepaticus, this so-called monocyte/M “waterfall” expanded
dramatically and consisted mostly of Ly6Chi MHCII–/ monocytes and CX3CR1int
Ms, with less expansion of fully mature CX3CR1hi Ms. Although these findings are
consistent with previous work, e.g., in chemically induced colitis (6), and suggest
that the normal process of monocyte/M differentiation is arrested, it is important
to note that the absolute numbers of mature Ms were actually increased in our
mice with H. hepaticus-induced colitis and remained so for the duration of the
11-week experiment. Thus, although the majority of infiltrating monocytes may be
short lived in the colitic mucosa, a proportion of these cells may still develop into
mature CX3CR1hi Ms, even in the face of inflammation. How the Ms recruited
under these conditions might contribute to the inflammation or its resolution and
if they eventually acquire all the properties of the normal, resident population
remain to be determined, as do the relative contributions of newly recruited and
preexisting cells to the “resident” M compartment.
Although methods were not available to examine and track infiltrating monocytes
directly following their arrival in the gut, we were able to explore whether the total
mature M population was altered in function during H. hepaticus colitis. In steady-



































































































































































































































































FIG 5 Colonic CX3CR1int monocytes/Ms produce proinflammatory mediators during H. hepaticus colitis. Cx3cr1/gfp mice were
inoculated with H. hepaticus and treated weekly with anti-IL-10R to induce colitis. Two weeks later, colonic LP CD64 CX3CR1int and
CD64 CX3CR1hi cells (both pregated on CD45 CD11b Ly6G SiglecF) were FACS purified and processed for RT-qPCR analysis of
proinflammatory mediators. Uninfected mice, mice given H. hepaticus alone, and mice given anti-IL-10R alone were included as
controls. Transcript levels of IL-1 (Il1b) (A), iNOS (Nos2) (B), IL-23p19 (Il23a) (C), and IL-12p35 (Il12a) (D) relative to TATA-binding
protein (TBP) in uninfected, H. hepaticus alone, anti-IL-10R alone, and H. hepaticus plus anti-IL-10R groups. Each symbol represents a
pool of 3 mice (for uninfected, H. hepaticus alone, and anti-IL-10R alone) or individual mice (for H. hepaticus plus anti-IL-10R). Data are
pooled from two individual experiments. Significance was determined by unpaired Student’s t test. *, P  0.05; **, P  0.01; ***, P 
0.001.
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constitutive production of IL-10 and low levels of TNF-, together with an inability to
respond to stimuli such as TLR ligands, but it has been unclear whether these properties
can change during inflammation (30). In contrast to their CX3CR1hi counterparts, as we
show here, cells within the CX3CR1int compartment are actively proinflammatory,
expressing much higher levels of mRNA for proinflammatory mediators such as IL-1,
iNOS, IL-23, and IL-12 during H. hepaticus colitis than their control counterparts. In
parallel, CX3CR1hi Ms taken at the peak of inflammation showed no increased
expression of IL-1 or IL-12 mRNA and only a modest increase in iNOS and IL-23 mRNA,
suggesting some, but limited, ability to adopt a proinflammatory phenotype under
these circumstances. In DSS colitis, we and others have shown that resident Ms do not
acquire proinflammatory characteristics (6, 12), but this has been reported in models of
colitis where IL-10-mediated signaling is absent, with wider alterations in gene expres-
sion than we tested here (18). While this contrasting behavior in the presence and
absence of IL-10 is yet to be confirmed in other models of inflammation, the results are
consistent with recent evidence that IL-10 drives permanent, epigenetic silencing of
proinflammatory genes (31). As a result, the absence of IL-10R-mediated signaling
profoundly alters the genetic landscape of mature intestinal Ms, allowing them to
respond to stimuli to which they are normally resistant (18). Whether IL-10 also controls
other aspects of intestinal M differentiation is unclear, although it has been reported
that their expression of the scavenger receptor CD163 is dependent on IL-10 (14).
Arnold et al. showed reduced levels of CD206 on CX3CR1hi Ms in H. hepaticus colitis
(28), but it is not clear whether this reflects an intrinsic effect of IL-10 or is secondary
to the effects of inflammation. That resident Ms retain a substantial proportion of their
homeostatic properties in the absence of IL-10 is suggested by our finding that
sustained expansion of this population is not accompanied by maintenance of H.
hepaticus-dependent immunopathology.
The colitis induced by H. hepaticus is dependent on IL-23 (22), and upregulation of
this cytokine was one of the major changes that we and others observed in CX3CR1int
CD11b myeloid cells in this model (28). It has often been difficult to identify precisely
the cell responsible for producing IL-23 in infection or inflammation, in great part
because Ms and DCs share many phenotypic features such as CD11c, MHCII, CX3CR1,
and CD11b. Therefore, it is important to note that by using rigorous gating strategies
based on CD64 as a M marker, both we and Arnold et al. (28) show that IL-23 was
derived from the M lineage, which is consistent with work in other models (7, 32, 33).
Notably, however, we detected increased IL-12p35 and IL-23p19 transcript levels in
elicited CX3CR1int monocytes/Ms, suggesting that these cells produce both IL-12 and
IL-23 during H. hepaticus-induced intestinal inflammation. Thus, we propose that the
TH17 response and subsequent phenotype switching of TH17 cells into IFN-
 IL-17A
lymphocytes in H. hepaticus colitis (23) is driven by IL-23 derived from Ms, presumably
activated directly by products of the organism. Nevertheless, it should be noted that
both CD103 CD11b and CD103 CD11b DCs from the intestine have been shown
to be capable of driving TH17 responses in vivo and in vitro, respectively, via production
of IL-23 and/or IL-6 (26, 35–37). Thus, there may be flexibility between the M and DC
lineages in their ability to stimulate TH17 activity depending on the stimulus. Alterna-
tively, these cell types may cooperate in driving such T-cell responses, perhaps with
migratory DCs being responsible for priming TH17 cells in the draining lymph node,
while tissue-resident Ms may sustain the survival of these cells once they migrate back
to the mucosa (38).
Together, our results show that elicited monocyte-derived CX3CR1int macrophages
form the predominant proinflammatory macrophage population in H. hepaticus-
induced colitis. Given that these cells appear to derive from the same Ly6Chi blood
monocytes as their homeostatic counterparts, identifying the factors that govern
monocyte fate in the colon during homeostasis versus inflammation could provide new
therapeutic targets for the treatment of IBD.
Bain et al. Infection and Immunity















































Infection and antibody treatment of mice. Female C57BL/6 (B6) Il10/, B6 WT, and B6 CD45.1
Cx3cr1gfp/gfp mice (obtained from Jackson Laboratory) and B6 CD45.1 Cx3cr1/gfp mice (generated by
crossing Cx3cr1gfp/gfp mice with B6 CD45.1 WT animals) were bred and maintained in an accredited
specific-pathogen-free (SPF) facility, and the experiments were conducted in accordance with the UK
Animals (Scientific Procedures) Act 1986 under a project license authorized by the UK Home Office and
approved by the University of York Animal Welfare and Ethical Review Body. The mice tested negative
for antibodies to specific murine viruses, were free of Helicobacter spp. as assessed by PCR, and were 6
weeks old when used.
Mice were allocated to treatment groups and inoculated i.g. with 1.5  107 bacteria of H. hepaticus
NCI-Frederick isolate 1A (39), derived originally from the same mouse colony as isolate Hh-1 (34)
(American Type Culture Collection strain 51449). IL-10-sufficient mice were also treated intraperitoneally
(i.p.) with 1 mg of anti-IL-10R (clone 1B1.3a) on days 0, 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70 of H.
hepaticus infection. Age- and sex-matched uninfected animals were included as controls. One week after
the last monoclonal antibody (MAb) injection, mice were sacrificed and intestines were collected for
analysis.
LP cell isolation. For the experiments shown in Fig. 1 and 2, colon and cecum were pooled from
individual mice and digested with Liberase Cl (0.42 mg/ml; Roche, Burgess Hill, UK) and DNase I (125
U/ml; Sigma-Aldrich, Gillingham, UK), followed by enrichment of lamina propria (LP) cells on 40/80%
Percoll gradients as described previously (23). For the experiments shown in Fig. 3 to 5 and in the
supplemental figures, colonic LP cells were isolated as described previously without the use of Percoll
gradients (4, 40).
Flow cytometric analysis and FACS. After blocking Fc receptors with anti-FcRII/III MAb (2.4G2; BD
Biosciences), LP cells were stained at 4°C with fluorochrome-conjugated antibodies (see Table S1 in the
supplemental material) for 20 to 30 min in the dark before being washed in FACS buffer (2% fetal calf
serum [FCS] and 1 mM EDTA in phosphate-buffered saline [PBS]) and then analyzed on a CyAn ADP
(Beckman Coulter, High Wycombe, UK) or LSRII/FACSAria I (BD Bioscience) flow cytometer. Data were
analyzed using FlowJo software (Tree Star Inc., OR, USA). Myeloid cell populations (as defined in figure
legends) were sorted using a MoFlo Astrios or a FACSAria I sorter, with purities of 96%. For flow
cytometric analyses on BD instruments, automatic compensation was performed in FACSDiva using
UltraComp or OneComp beads together with fluorescence-minus-one controls.
Intracellular cytokine staining. Large intestinal LP cells (2  106/ml) from uninfected and 2-week
H. hepaticus-infected Il10/ mice were cultured in medium alone or in the presence of 10 g/ml
Pam3CSK4 (InvivoGen, Toulouse, France) for 4 h at 37°C with 10 g/ml brefeldin A during the last 3 h.
Thereafter, cells were stained for surface markers (CD45 and CD11b) and intracellular TNF- as described
previously (23).
Analysis of cytokine protein and mRNA expression. For cytokine protein analysis, FACS-purified
CD45 CD11b cells were cultured in 96-well round-bottomed plates (5  104 cells/ml; 0.2 ml/well) at
37°C and 5% CO2 in medium alone or with 10 g/ml ultrapure Escherichia coli LPS or 10 g/ml Pam3CSK4
(both from InvivoGen, Toulouse, France) or 10 g/ml soluble H. hepaticus antigen (SHelAg) prepared as
described previously (21, 41). After 24 h, supernatants were collected and analyzed by ELISA for IL-12p40
(Mabtech, Nacka Strand, Sweden) and IL-6 (R&D Systems) and by FlowCytoMix for TNF- (Bender
MedSystems, Vienna, Austria).
For cytokine RT-qPCR analysis in Fig. 2, FACS-purified CD45 CD11b cells were homogenized in
TRIzol, and total RNA was isolated by chloroform extraction and reverse transcribed using SuperScript II
and random hexamers. cDNA was amplified using SYBR green reagents and an ABI Prism RT-PCR system
(Applied Biosystems). Cytokine expression levels for each individual sample (run in duplicates) were
normalized to hypoxanthine phosphoribosyltransferase (HPRT) using threshold cycle (ΔCT) calculations
and the 7000 System SDS software (Applied Biosystems). For myeloid cell populations in Fig. 5,
FACS-purified cells were lysed in RLT buffer (Qiagen) and homogenized using QIAshredders (Qiagen).
RNA was then isolated and purified using an RNeasy microkit (Qiagen) and reverse transcribed using a
high-capacity RNA-to-cDNA kit (Life Technologies) and random hexamers. cDNA was amplified using
SYBR green reagents and an ABI 7900HT Prism RT-PCR system (Applied Biosystems). Cytokine expression
levels for each individual sample (run in triplicates) were normalized to TATA-binding protein (TBP) using
ΔCT calculations. Specific primer pairs are detailed in Table S2.
Statistical analysis. Multiple group comparisons were performed by one-way analysis of variance
(ANOVA), while Student’s t test and the Mann-Whitney test were used to compare two groups.
Differences were considered statistically significant with a P value of 0.05.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/IAI
.00579-17.
SUPPLEMENTAL FILE 1, PDF file, 0.6 MB.
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